TURNER DANIEL K III

CIK 00012802496 companiesLA JOLLA, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001280249

Recent Transactions

50 trades

Exercise of In-Money
SI-BONE, Inc.$SIBN
Series 5 Preferred Stock
2018-10-19+15,496→ 1,112,312 total
Conversion
SI-BONE, Inc.$SIBN
Common Stock
2018-10-19+1,102,915→ 1,102,915 total
Sale
SI-BONE, Inc.$SIBN
Series 5 Preferred Stock
2018-10-19$15.00/sh−9,397→ 1,102,915 total
Conversion
SI-BONE, Inc.$SIBN
Common Stock
2018-10-19+597,071→ 1,699,986 total
Conversion
SI-BONE, Inc.$SIBN
Common Stock
2018-10-19+51,827→ 130,391 total
Conversion
SI-BONE, Inc.$SIBN
Common Stock
2018-10-19+171,929→ 171,929 total
Exercise of In-Money
SI-BONE, Inc.$SIBN
Warrant (right to buy)
2018-10-19−15,496→ 0 total
Conversion
SI-BONE, Inc.$SIBN
Series 5 Preferred Stock
2018-10-19−1,102,915→ 0 total
Conversion
SI-BONE, Inc.$SIBN
Series 6 Preferred Stock
2018-10-19−563,926→ 0 total
Conversion
SI-BONE, Inc.$SIBN
Series 7 Preferred Stock
2018-10-19−171,929→ 0 total
Conversion
SI-BONE, Inc.$SIBN
Series 5 Preferred Stock
2018-10-19−78,564→ 0 total
Conversion
SI-BONE, Inc.$SIBN
Series 6 Preferred Stock
2018-10-19−48,950→ 0 total
Conversion
SI-BONE, Inc.$SIBN
Series 7 Preferred Stock
2018-10-19−27,409→ 0 total
Conversion
SI-BONE, Inc.$SIBN
Common Stock
2018-10-19+78,564→ 78,564 total
Conversion
SI-BONE, Inc.$SIBN
Common Stock
2018-10-19+27,409→ 1,727,395 total
Conversion
MINDBODY, Inc.
Common Stock
2015-06-24+19,668→ 336,633 total
Conversion
MINDBODY, Inc.
Series A Preferred Stock
2015-06-24−12,042→ 0 total
Conversion
MINDBODY, Inc.
Series A Preferred Stock
2015-06-24−145→ 0 total
Conversion
MINDBODY, Inc.
Series B Preferred Stock
2015-06-24−7,412→ 0 total
Other
MINDBODY, Inc.
Common Stock
2015-06-24−594,349→ 0 total
Conversion
MINDBODY, Inc.
Common Stock
2015-06-24+590,554→ 594,349 total
Other
MINDBODY, Inc.
Common Stock
2015-06-24−336,633→ 0 total
Other
MINDBODY, Inc.
Class B Common Stock
2015-06-24+336,633→ 336,633 total
Conversion
MINDBODY, Inc.
Series B Preferred Stock
2015-06-24−87→ 0 total
Conversion
MINDBODY, Inc.
Series G Preferred Stock
2015-06-24−590,320→ 0 total
Other
MINDBODY, Inc.
Class B Common Stock
2015-06-24+594,349→ 594,349 total
Purchase
Orexigen Therapeutics, Inc.
Common Stock
2011-12-22$1.45/sh+28,602→ 177,958 total
Purchase
Orexigen Therapeutics, Inc.
Warrant to Purchase Common Stock
2011-12-22$14.49/sh+28,602→ 28,602 total
Purchase
Orexigen Therapeutics, Inc.
Warrant to Purchase Common Stock
2011-12-22$14.49/sh+28,602→ 28,602 total
Purchase
Orexigen Therapeutics, Inc.
Common Stock
2011-12-22$1.45/sh+28,602→ 377,958 total
Award
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2011-06-02+20,000→ 20,000 total
Sale
Paratek Pharmaceuticals, Inc.
Common Stock
2011-03-29$8.17/sh−65,000→ 569,361 total
Sale
Paratek Pharmaceuticals, Inc.
Common Stock
2011-03-29$8.17/sh−65,000→ 471,749 total
Award
Paratek Pharmaceuticals, Inc.
Common Stock (right to buy)
2011-01-27+7,000→ 7,000 total
Sale
Orexigen Therapeutics, Inc.
Common Stock
2010-12-23−48,057→ 498,712 total
Sale
Orexigen Therapeutics, Inc.
Common Stock
2010-12-22$8.25/sh−51,943→ 546,769 total
Sale
Orexigen Therapeutics, Inc.
Common Stock
2010-12-13−266,365→ 598,712 total
Sale
Orexigen Therapeutics, Inc.
Common Stock
2010-12-10−333,635→ 865,077 total
Award
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2010-05-27+20,000→ 20,000 total
Sale
Pernix Sleep, Inc.
Common Stock
2010-03-18$6.38/sh−1,500,000→ 695,505 total
Award
Paratek Pharmaceuticals, Inc.
Common Stock Option (right to buy)
2010-02-03+1,900→ 1,900 total
Award
Paratek Pharmaceuticals, Inc.
Common Stock Option (right to buy)
2010-01-14+4,000→ 4,000 total
Sale
Orexigen Therapeutics, Inc.
Common Stock
2009-12-17$7.55/sh−100,000→ 1,198,712 total
Sale
Orexigen Therapeutics, Inc.
Common Stock
2009-09-22$10.22/sh−100,000→ 1,298,712 total
Sale
Orexigen Therapeutics, Inc.
Common Stock
2009-09-17$9.28/sh−100,000→ 1,398,712 total
Sale
Orexigen Therapeutics, Inc.
Common Stock
2009-09-16$8.93/sh−40,904→ 1,498,712 total
Sale
Orexigen Therapeutics, Inc.
Common Stock
2009-09-15$8.96/sh−135,701→ 1,539,616 total
Sale
Orexigen Therapeutics, Inc.
Common Stock
2009-09-14$9.00/sh−23,395→ 1,675,317 total
Sale
Paratek Pharmaceuticals, Inc.
Common Stock
2009-09-10$13.00/sh−14,000→ 541,249 total
Sale
Paratek Pharmaceuticals, Inc.
Common Stock
2009-09-10$13.00/sh−2,574→ 59,628 total

Companies

Recent Filings

Address

C/O OREXIGEN THERAPEUTICS, INC. 3344 N. TORREY PINES COURT, SUITE 200

LA JOLLA, CA, 92037

View on SEC.gov